Rapport
EMCDDA-Europol Joint Report on a new psychoactive substance: methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
Europol
Année
2016
Page(s) :
20 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
;
The Hague : Europol
Collection :
Joint reports
ISBN :
978-92-9168-925-5
Domaine :
Autres substances / Other substances
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Organismes
OEDT
Thésaurus mots-clés
DROGUES DE SYNTHESE
;
CHIMIE
;
PHENOMENE EMERGENT
;
CONTROLE DES STUPEFIANTS
;
ANALYSE CHIMIQUE
;
TOXICOLOGIE
;
SAISIE
;
PRODUCTION
;
INTOXICATION
;
FACTEUR DE RISQUE
;
PHARMACOLOGIE
;
CANNABINOIDES
;
TRAFIC
;
DIFFUSION DES PRODUITS
;
PRIX
Thésaurus géographique
EUROPE
Résumé :
In February 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate, commonly known as MDMB-CHMICA, through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on MDMB-CHMICA as stipulated by Article 5.1 of the Council Decision.
Historique